Search alternatives:
cell decrease » cell disease (Expand Search), mean decrease (Expand Search), cell release (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
myeloid small » myeloid cell (Expand Search)
euploid cell » myeloid cell (Expand Search)
cell decrease » cell disease (Expand Search), mean decrease (Expand Search), cell release (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
myeloid small » myeloid cell (Expand Search)
euploid cell » myeloid cell (Expand Search)
-
21
-
22
Table_1_Dual targeting of glutamine and serine metabolism in acute myeloid leukemia.xlsx
Published 2024“…<p>Acute myeloid leukemia (AML) is a heterogeneous hematological malignancy characterized by disrupted blood cell production and function. …”
-
23
DataSheet_1_Dual targeting of glutamine and serine metabolism in acute myeloid leukemia.pdf
Published 2024“…<p>Acute myeloid leukemia (AML) is a heterogeneous hematological malignancy characterized by disrupted blood cell production and function. …”
-
24
Table1_Mitochondrial DNA mutations can influence the post-implantation development of human mosaic embryos.xlsx
Published 2023“…</p><p>Discussion: Our results indicate that aneuploid cells decrease in human embryos post-implantation, and mtDNA mutations might induce low mitochondrial function and influence the development of post-implantation embryos with not only aneuploidy but also euploidy. …”
-
25
Table5_Mitochondrial DNA mutations can influence the post-implantation development of human mosaic embryos.DOCX
Published 2023“…</p><p>Discussion: Our results indicate that aneuploid cells decrease in human embryos post-implantation, and mtDNA mutations might induce low mitochondrial function and influence the development of post-implantation embryos with not only aneuploidy but also euploidy. …”
-
26
-
27
-
28
Image3_Honokiol Induces Ferroptosis by Upregulating HMOX1 in Acute Myeloid Leukemia Cells.pdf
Published 2022“…<p>Acute myeloid leukemia (AML) is one of the malignant hematological cancers with high mortality. …”
-
29
Image1_Honokiol Induces Ferroptosis by Upregulating HMOX1 in Acute Myeloid Leukemia Cells.pdf
Published 2022“…<p>Acute myeloid leukemia (AML) is one of the malignant hematological cancers with high mortality. …”
-
30
Image2_Honokiol Induces Ferroptosis by Upregulating HMOX1 in Acute Myeloid Leukemia Cells.pdf
Published 2022“…<p>Acute myeloid leukemia (AML) is one of the malignant hematological cancers with high mortality. …”
-
31
DataSheet1_Honokiol Induces Ferroptosis by Upregulating HMOX1 in Acute Myeloid Leukemia Cells.xlsx
Published 2022“…<p>Acute myeloid leukemia (AML) is one of the malignant hematological cancers with high mortality. …”
-
32
DataSheet_1_Ascorbate Inhibits Proliferation and Promotes Myeloid Differentiation in TP53-Mutant Leukemia.pdf
Published 2021“…We found that the addition of ascorbate had a minimal effect on Prima-1<sup>Met</sup>–induced cytotoxicity, with small increases or decreases in cytotoxicity being observed depending on the timing of treatment. …”
-
33
LncRNA SNHG4 regulates miR-10a/PTEN to inhibit the proliferation of acute myeloid leukemia cells
Published 2020“…<p><b>Objectives:</b> Long non-coding RNA (lncRNA) small nucleolar RNA host gene 4 (SNHG4) is a characterized oncogenic lncRNA in osteosarcoma. …”
-
34
Image_2_Biodegradable nanoparticles induce cGAS/STING-dependent reprogramming of myeloid cells to promote tumor immunotherapy.tif
Published 2022“…ONP-302 infusion decreased tumor growth via the activation of the cGAS/STING pathway within myeloid cells, and subsequently increased NK cell activation via an IL-15-dependent mechanism. …”
-
35
Table_7_Biodegradable nanoparticles induce cGAS/STING-dependent reprogramming of myeloid cells to promote tumor immunotherapy.pdf
Published 2022“…ONP-302 infusion decreased tumor growth via the activation of the cGAS/STING pathway within myeloid cells, and subsequently increased NK cell activation via an IL-15-dependent mechanism. …”
-
36
Table_2_Biodegradable nanoparticles induce cGAS/STING-dependent reprogramming of myeloid cells to promote tumor immunotherapy.pdf
Published 2022“…ONP-302 infusion decreased tumor growth via the activation of the cGAS/STING pathway within myeloid cells, and subsequently increased NK cell activation via an IL-15-dependent mechanism. …”
-
37
Table_8_Biodegradable nanoparticles induce cGAS/STING-dependent reprogramming of myeloid cells to promote tumor immunotherapy.pdf
Published 2022“…ONP-302 infusion decreased tumor growth via the activation of the cGAS/STING pathway within myeloid cells, and subsequently increased NK cell activation via an IL-15-dependent mechanism. …”
-
38
Image_1_Biodegradable nanoparticles induce cGAS/STING-dependent reprogramming of myeloid cells to promote tumor immunotherapy.tif
Published 2022“…ONP-302 infusion decreased tumor growth via the activation of the cGAS/STING pathway within myeloid cells, and subsequently increased NK cell activation via an IL-15-dependent mechanism. …”
-
39
Image_4_Biodegradable nanoparticles induce cGAS/STING-dependent reprogramming of myeloid cells to promote tumor immunotherapy.tif
Published 2022“…ONP-302 infusion decreased tumor growth via the activation of the cGAS/STING pathway within myeloid cells, and subsequently increased NK cell activation via an IL-15-dependent mechanism. …”
-
40
Image_5_Biodegradable nanoparticles induce cGAS/STING-dependent reprogramming of myeloid cells to promote tumor immunotherapy.tif
Published 2022“…ONP-302 infusion decreased tumor growth via the activation of the cGAS/STING pathway within myeloid cells, and subsequently increased NK cell activation via an IL-15-dependent mechanism. …”